Todd Fox

11PUBLICATIONS
59CO-AUTHORS
Cell development, proliferation and deathHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 01, 2026
Glucosylceramide synthase is required for C6-ceramide nanoliposome-induced organelle stress and cell death.

|Sep 30, 2026
Very Long Chain Fatty Acid Synthesis is a Targetable Dependency in RAS Pathway Mutant Leukemia.

|Sep 02, 2025
Nanoromidepsin, a polymer nanoparticle of the HDAC inhibitor, improves safety and efficacy in models of T-cell lymphoma.

Ipsita Pal, Anuradha Illendula, Andrea Joyner

|Mar 13, 2024
Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells.

Yuki Ohya, Yuri Ogiso, Masaya Matsuda

|Dec 23, 2023
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia.

Johnson Ung, Su-Fern Tan, Todd E Fox

|Mar 29, 2023
Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia.

Kelsey H Fisher-Wellman, Miki Kassai, James T Hagen

Pageof 2

Frequent Collaborators

4 joint publications

David J Feith

2 joint publications

David F Claxton

2 joint publications

Jeremy J P Shaw

2 joint publications

Upendarrao Golla